The 24th Annual Meeting of the German Society for Radiation Oncology, Deutschen Gesellschaft fur Radioonkologie (DEGRO), is organized by MCI Deutschland GmbH and will be held during Jun 21 - 24, 2018 at Congress Center Leipzig in Germany. The target audience for this medical event is Radiation Oncologists and Oncologists.
The REQUITE abstract "Patient reported outcomes and acute toxicity assessment in REQUITE study patients receiving hypofractionation versus standard fractionation doses among prostate cancer patients", I. Helmbold et al., has been accepted as a talk for the DEGRO conference. Irmgard Helmbold, study physician, will present results on hypofractionation and acute toxicity among prostate cancer patients and also preliminary findings for late toxicity in the presentation session "Prostatakarzinom" on 23rd June 2018. To read the abstract click here